ExodusPoint Capital Management’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-189,177
| Closed | -$549K | – | 1375 |
|
2025
Q1 | $549K | Buy |
189,177
+116,670
| +161% | +$339K | 0.01% | 1031 |
|
2024
Q4 | $258K | Buy |
72,507
+24,984
| +53% | +$88.9K | ﹤0.01% | 1204 |
|
2024
Q3 | $237K | Buy |
+47,523
| New | +$237K | ﹤0.01% | 1314 |
|
2024
Q2 | – | Sell |
-52,168
| Closed | -$222K | – | 1372 |
|
2024
Q1 | $222K | Buy |
52,168
+26,089
| +100% | +$111K | ﹤0.01% | 1204 |
|
2023
Q4 | $53K | Buy |
+26,079
| New | +$53K | ﹤0.01% | 1308 |
|
2022
Q2 | – | Sell |
-11,140
| Closed | -$29K | – | 1860 |
|
2022
Q1 | $29K | Sell |
11,140
-13,335
| -54% | -$34.7K | ﹤0.01% | 2030 |
|
2021
Q4 | $95K | Buy |
+24,475
| New | +$95K | ﹤0.01% | 1918 |
|
2021
Q3 | – | Sell |
-13,399
| Closed | -$53K | – | 2024 |
|
2021
Q2 | $53K | Buy |
+13,399
| New | +$53K | ﹤0.01% | 2136 |
|
2020
Q4 | – | Sell |
-26,808
| Closed | -$130K | – | 1863 |
|
2020
Q3 | $130K | Buy |
+26,808
| New | +$130K | ﹤0.01% | 1500 |
|